Biomed Lublin Wytwornia Surowic I Szczepionek SA operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biomed Lublin Wytwornia Surowic I Szczepionek SA with three other
pharmaceutical manufacturers in Europe:
sales of 8.73 million Euro [US$10.72 million]
of which 72%
was Research & Development Tax Credit),
Bonesupport Holding AB
(104.60 million Swedish Kronor [US$12.77 million]
of which 76%
was CERAMENT BVF), and
based in Germany
(6.50 million Euro [US$7.99 million]
Biomed Lublin Wytwornia Surowic I Szczepionek SA reported sales of 36.34 million Polish New Zlotys (US$10.59 million)
December of 2016.
decrease of 14.7%
versus 2015, when the company's sales were 42.59 million Polish New Zlotys.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Biomed Lublin Wytwornia Surowic I Szczepionek SA had sales
of 38.41 million Polish New Zlotys.